Bandaríkin - enska - NLM (National Library of Medicine)

mylan institutional llc - methotrexate (unii: yl5fz2y5u1) (methotrexate - unii:yl5fz2y5u1) - methotrexate 1 g in 40 ml

Bandaríkin - enska - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc. - methotrexate (unii: yl5fz2y5u1) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml

Bandaríkin - enska - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml

Bandaríkin - enska - NLM (National Library of Medicine)

mylan institutional llc - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml

Bandaríkin - enska - NLM (National Library of Medicine)

fresenius kabi usa, llc - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 1 g

Bandaríkin - enska - NLM (National Library of Medicine)

hospira, inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml

Bandaríkin - enska - NLM (National Library of Medicine)

fresenius kabi usa, llc - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml

Bandaríkin - enska - NLM (National Library of Medicine)

teva parenteral medicines, inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. in acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is also indicated in the treatment of meningeal leukemia. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin's lymphomas. methotrexate in high doses followed by leucovorin rescue in combination with other chemotherapeutic agents is effective in prolonging relapse-free survival in patients with non-metastatic osteosarcoma who have undergone surgical resection

Malta - enska - Medicines Authority

recordati rare disease immeuble “le wilson”, 70, avenue du général de gaulle, f-92800 puteaux, france - powder for solution for injection - dactinomycin 0.5 mg - antineoplastic agents

Írland - enska - HPRA (Health Products Regulatory Authority)

hospira uk limited - vincristine sulfate - solution for inj/inf - 1 micromol - vinca alkaloids and analogues